Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series
Publication date: October 2026 Source: Transplantation Proceedings, Volume 58, Issue 8 Author(s): Srilekha Sridhara, Elizabeth L. Cho, Joelle E. Nelson, Hasan A. Khamash, Sami Alasfar, Ruby J. Siegel, Girish K. Mour, Pooja Budhiraja, Lavanya Kodali, Bekir Tanriover, Bassam G. Abu Jawdeh
Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series. // Transplantation Proceedings. – URL: https://www.sciencedirect.com/science/article/pii/S0041134526003921?dgcid=rss_sd_all
Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series. Transplantation Proceedings. https://www.sciencedirect.com/science/article/pii/S0041134526003921?dgcid=rss_sd_all
“Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series.” Transplantation Proceedings.
@article{article108902,
title = {Daratumumab in Antibody-Mediated Rejection After Kidney Transplantation: Mechanistic Rationale, Published Clinical Experience, and a Single-Center Case Series},
journal = {Transplantation Proceedings},
url = {https://www.sciencedirect.com/science/article/pii/S0041134526003921?dgcid=rss_sd_all}
}